It was identified that adiponectin may reduce atherosclerotic plaque and improve the stability of plaques in ApoE−/− mice with atherosclerosis by inhibiting inducible nitric oxide synthase (iNOS) and oxidative/nitrative stress. Here, ADIPOQ is linked to atherosclerosis.